Search - tctmd.com

Displaying 261 - 280 of 500

Sort: Relevancy | Date

News Daily News

Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population

Todd Neale

September 18, 2019

News Daily News

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

Caitlin E. Cox

September 17, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Yael L. Maxwell

September 02, 2019

News Daily News

Decline in US Deaths From CVD and Diabetes Is Leveling Off

Todd Neale

August 27, 2019

News Conference News SCCT 2019

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Yael L. Maxwell

July 16, 2019

News Daily News

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Marcus A. Banks

July 16, 2019

News Daily News

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

Alison Palkhivala

July 05, 2019

News Industry News

Health Library: Hypertension (High Blood Pressure)

June 24, 2019

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Conference News EuroPCR 2019

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

L.A. McKeown

June 06, 2019

News Conference News EAS 2019

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

Michael O'Riordan

June 04, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Conference News EAS 2019

Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis

Michael O'Riordan

May 28, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

Patients Stop CVD Medications When Their Pharmacy Closes

Michael O'Riordan

April 19, 2019

News Daily News

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

Michael O'Riordan

April 18, 2019

News Daily News

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Caitlin E. Cox

April 18, 2019

Advertisement

Polypill Drops BP, LDL Cholesterol in a Disadvantaged US Population

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Decline in US Deaths From CVD and Diabetes Is Leveling Off

CTA or Function Tests in High-risk Chest Pain and No Known CAD: Debate Goes On

Race, Wealth, and Neighborhood Predict Bystander CPR in Children

Multiple Passes During Stroke Thrombectomy Ups Risk of Blood-Brain Barrier Disruption

Health Library: Hypertension (High Blood Pressure)

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation

Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Clear CVD Risk Reduction With PCSK9 Inhibitors, but No Mortality Effect: Meta-analysis

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Mortality From Heart Failure Increasing in United States

Patients Stop CVD Medications When Their Pharmacy Closes

Help, Not Harm: Omega-6 PUFAs Linked With Lower Risk of CVD Events

African-American, but Not Hispanic/Latina, Women Have More MIs After Stenting Than White Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content